PTSC.OB

[la-onda]

rebouncing soon 

THE OUTLOOK

Patriot Scientific has emerged as an effective and dynamic intellectual property licensing company, developing and marketing innovative and proprietary semiconductor technologies. The company's portfolio of proprietary designs encompasses what is believed to be fundamental ultra-lowpower array microprocessor technology, as well as pending patents designed to protect Patriot's proprietary technology.

The patent portfolio, marketed as the Moore Microprocessor PatentTM (MMP) Portfolio, contains intellectual property jointly owned by Patriot and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as European and Japanese patents. Protected through year 2015, the patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processor (DSPs), embedded processors and System-on-Chip (SoC) implementations.

The intellectual property represented by the MMP Portfolio of patents encompasses building blocks for virtually all digital products being designed and shipped today. This includes techniques used in devices ranging from TV remote controls to sophisticated medical diagnostic equipment, portable media players and complex Internet backbone hardware. Today's automobiles have dozens of such devices. Global sales of end products deploying chips using technologies protected by the jointly owned patents are estimated to be greater than $200 billion annually.
The MMP portfolio-licensing program headed by TPL under the Alliacense brand rewards first movers in their industry sectors with substantial discounts. By design, the licensing structure enables early adapter manufacturers to disadvantage their competitors. Alliacense said it has contacted hundreds of system manufacturers around the globe.
Patriot management says Alliacense is continuing to produce results that confirm the company's confidence in their strategies. Revenues from licenses have resulted in a significant fiscal strengthening of Patriot Scientific.
In 2006, the company has paid two cash dividends to shareholders totaling $25 million. This includes a $0.02 dividend paid March 22 and a $0.04 cash dividend paid April 24.
In September, Kenwood joined an expanding group of global system manufacturers, including PENTAX, Seiko Epson, Nikon, Sony, Fujitsu, Casio, Hewlett-Packard and Olympus that have become MMP Portfolio licensees this calendar year.

Alliacense noted the Sony settlement highlights the remarkably broad range of everyday products that use microprocessor technology. Alliacense said it is in discussions with dozens of companies and that competition for early-round licensing berths in key market sectors has become intense.

http://www.hawkassociates.com/ptscprofile.aspx

[Stocky2000]

i opened a position at 0.74 let s see 

[422fwhp]

I did the same thing at .745

GLTA....Jody

[rickjust]

hi,
would like to see it get back above the 200ma
max

[setravis]

PTSC.OB Threads have been Merged.
Please use the search before starting new threads on a Stock Pick.
Chances are a thread already exist.
So why not post whatever you have to comment about on that pick to that thread.
"Simplicity" My fellow traders.   
All history on a stock pick in 1 thread is awesome.   

Thank You....and good luck with all your trades....make some $$$


I will also attach Friday's closing chart

[buddjas1]

Dutton announces $1.06 price target.  Now $0.62.

Could be just what this stock needs to take off again.

http://biz.yahoo.com/bw/061127/20061127005649.html?.v=1

[la-onda]

please read the 21 sides Dutton report update:
http://www.jmdutton.com/research/ptsc/reports/ptsc_report_112706.pdf

[horwel]

News


Agilent Technologies Becomes Tenth Major Manufacturer to Purchase Moore Microprocessor Patent™ Portfolio License During 2006
MMP Portfolio licensing program continues to focus on system manufacturing leaders


CUPERTINO, Calif. – Nov. 27, 2006 – Alliacense today announced that Agilent Technologies has purchased from The TPL Group a license to use the Moore Microprocessor Patent™ (MMP) Portfolio. As the tenth company to purchase an MMP Portfolio license this year, Agilent Technologies is preceded by HP, Casio, Fujitsu, Sony, Nikon, Seiko Epson, Pentax, Olympus and Kenwood.

"The global technology leaders that have purchased MMP Portfolio licenses this year recognize the competitive edge to be gained by licensing MMP technologies sooner rather than later," said Mike Davis, Alliacense Sr. Vice President, Licensing. "As we welcome Agilent Technologies to our distinguished roster of MMP licensees, we also want to encourage all electronic product manufacturers to contact us regarding the significant competitive advantages of becoming an early MMP Portfolio licensee."

According to Davis, Agilent Technologies has captured one of the "first-mover" MMP Portfolio licensing berths, which encompass Electronic Measurement, Bioanalytical Measurement, and Semiconductor Test Solutions products. Agilent Technologies is the world's premier measurement company providing core analytical and electrical instruments to the life sciences, chemical analysis, communications, and electronics industries. The company has two primary businesses: Bio-Analytical Measurement and Electronic Measurement. The company currently has approximately 20,000 employees and serves customers in more than 110 countries. Agilent had revenue of $5.1B in fiscal year 2005.

The MMP Portfolio patents, filed by The TPL Group in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment -- and automobiles which today have dozens of microprocessor-based key features and benefits.

About the MMP Portfolio

Named after legendary inventor Charles "Chuck" Moore, the MMP Portfolio includes seven US patents as well as their European and Japanese counterparts fundamental to the design of modern microprocessors, microcontrollers and system-on-chip devices. Developed in a joint venture between the TPL Group and Moore, the MMP Portfolio today is jointly owned by privately held TPL Group and publicly held Patriot Scientific Corporation (PTSC.OB).

About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development /management executives, Alliacense focuses on expanding the awareness and value of TPL's intellectual property portfolios. For more information, visit www.alliacense.com.



Alliacense and Moore Microprocessor Patent (MMP) are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.

     

[tokyopua]

Hi, hope I am in the right thread, this was the most recent and relevant one I could find in searches (the link in the moved thread didnt work).

Anyway, PTSC looking a bit interesting to me after Friday's hammer candle, setting up for a morning star reversal pattern Monday possiby.  It would be a bit of a gamble since the recent downtrend has been unrelenting given that the stock has lost over 50% in the last 2 months. 

Anyone know of fundamental reasons for this huge drop?  Anyway, looking to play this maybe with a tight stop, say somewhere just below .56 (the low of the other recent candle on 11/14).  Not sure yet though, would welcome any input.

[buddjas1]

Could roll today and the rest of the week.  Up in pre-market on news of another licensee. 


http://www.alliacense.com/Press_Release_Details.aspx?PressID=33

[setravis]

Hold on.......   If you are still in....
They are still making money and paying dividends, you cant beat that !
Ride this one out.........

[horwel]

What do you think,time to buy again?

[rickjust]

yes , please do
i am a bag holder so any buying to push the price higher would be much apreciated.
maxi

[horwel]

 

Bought a small position today

[la-onda]

Rating: Strong Speculative Buy
01/19/2007
Patriot Scientific Third Quarter Results Stronger Than Numbers Indicate; Reiterate Strong Speculative Buy Rating
Patriot Scientific Corporation (Patriot Scientific) released its results for the three months ending November 30, 2006. As we explained in our initial November 27, 2006, Research Report, when viewing Patriot Scientific's results, investors should become accustomed to operating results showing no patent royalty revenue on the top line of operating statements. Investors should concentrate on the equity in "Equity in earnings of affiliated company" line item in the Statement of Operations. In the three months ended November 30, 2006, Patriot Scientific reported $6,674,793 equity in earnings of affiliated company line item (i.e. Phoenix Digital). For the six months ended November 30, 2006, the equity in earnings of affiliated company line item was $18.7 million. The
equity in earnings of affiliated company line item represents the net license fees received, after expenses, from the joint venture entity,
Phoenix Digital. Phoenix Digital is jointly owned 50% by Patriot Scientific and 50% The TPL Group. Phoenix Digital receives income when manufacturers purchase licenses to use technology that is covered by patents in the MMP Patent Portfolio. The MMP portfolio, Phoenix Digital's Intellectual Property asset, is jointly owned by Patriot Scientific and TPL.
The press release noted that Phoenix Digital will be receiving license proceeds of $8,850,000 relating to an additional license agreement signed in November 2006, this amount is to be received by Phoenix Digital in January 2007. In addition, Phoenix Digital entered into additional licensing agreements with total income figures of $7,320,000 during December 2006. Thus, Phoenix Digital
already has total license income in the three months ending February 28, 2007, of at least $16,170,000. As noted above Patriot Scientific and The TPL Group will share this income, on a 50/50 basis, after Phoenix Digital's expenses.
Although Patriot Scientific reported a net loss of $1,881,998 for the three months ended November 30, 2006, this net loss is not indicative of the continuing positive results in this period. There was a one-time expense of $6,300,000 for a set aside to provide funds for settlement in principle of a dispute. This dispute relates to a lawsuit that had been filed by a co-inventor of patents in the MMP Patent Portfolio. The dispute went to mediation and was settled in principle in December 2006. Even though the settlement terms have
not been finalized, Patriot Scientific chose to accrue the $6,300,000 to cover the potential cash and stock settlements relating to the mediation agreement.
Patriot Scientific's balance sheet as of November 30, 2006, is strong, with current assets of $15,714,374, compared with $8,014,970 as
of May 31, 2006. Current liabilities as of November 30, 2006, were $10,968,204 (including $6,354,063 accrual for contingency fee discussed above and $4,154,600 accrued income tax payable), compared with $1,244,116 as of May 31, 2006. Cash and cash equivalents at November 30, 2006, showed an increase of $7,731,791 over the figure at May 31, 2006, to end the period at
$11,718,031. This cash figure reflects that in the six months ended November 30, 2006, Patriot Scientific utilized $4,046,106 to buy back, as part of a previously announced stock buy back program, 4,874,827 shares of its common stock at an average price or $0.83 per share. In the three months ended November 30, 2006, Patriot Scientific bought back 2,799,824 shares of its common stock at an average price of $0.78 per share.

SUMMARY
We began research coverage on Patriot Scientific on November 27, 2006, with a rating of Speculative Buy and a 12-month price target of $1.12. With the announcement of additional licenses, we raised our rating to a Strong Speculative Buy on December 12, 2006. Since then, Patriot Scientific's stock has traded in a range of a $0.43 low to a $0.65 high. Management indicated in today's press release, "that the strength of the patent portfolio continues to be validated by the 12 licenses that have been signed thus far with major electronics companies, 10 of them during calendar year 2006," and that their, "outlook remains positive for continued revenue based on further progress in licensing more of the over 400 companies worldwide that have been notified they are candidates."
We agree and most heartily reiterate our Strong Speculative Buy, and maintain our 12-month price target of $1.12 per share. We will shortly publish our Update Research Report, wherein we will present, in detail, our comments on the results of the period ended November 30, 2006, as outlined in the Company's 10Q filing.

http://www.jmdutton.com/research/ptsc/notes/ptsc_note_011907.pdf